According to Future Market Insights, the Global Pelvic Reconstruction Market was worth around US$ 270.5 million in 2021 and is expected to grow at a CAGR of 2.8% from 2022 to 2032, surpassing US$ 366.9 million in 2032. The increased use of vaginal mesh, slings, and pessaries in the healthcare sector as a result of rising cases of pelvic floor disorders is driving growth.
Furthermore, as the number of cases of pelvic disorders and deformities has increased, so has the demand for pelvic reconstruction products. As a result, key players are competing to develop systems that can be approved by regulatory bodies such as the FDA.
For In-depth insights, Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15500
Furthermore, the growing acceptance of pelvic floor reconstruction procedures in hospitals and specialty clinics is driving the development of advanced systems for precise and rapid recovery. There is also an increase in research and development on methods to treat pelvic floor disorders by reducing risk factors.
Tissue engineering is increasingly being used to support the pelvic floor and promote tissue repair. This is also more biocompatible than the standard approach of using polypropylene mesh. As a result, several ongoing studies focusing on tissue engineering, such as the use of fibroblasts and stem cells, are assisting in the growth of the pelvic reconstruction market.
Key Takeaways from Market Study
Because of the increasing prevalence of pelvic floor disorders, vaginal sling systems held a 2% market value share in 2021.
Surgical procedures are expected to lead the market in terms of procedures, accounting for approximately 9% of revenue in 2021.
According to projections, pelvic organ prolapse will grow at a CAGR of 7% during the forecast period.
The vaginal organ is the most affected of the pelvic organs, accounting for about 6% of the segment in 2021.
Because of the high prevalence of pelvic floor disorders in the region, North America is expected to be the leading region with a value share of 9% in 2021.
“Rising initiatives to promote safety and mitigate risk, as well as the increasing research and development for the improvement of treatment approaches is set to propel the sales of pelvic reconstruction products across the globe,” says an analyst of Future Market Insights.
Contact Us for a Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-15500
Market Competition
There are a number of local as well as established players in the market for pelvic reconstruction. There is increased research and development to meet the population’s current needs.
Ulrich et al. demonstrated in 2019 at Royal Hallamshire Hospital, UK, that endometrial MSCs seeded onto gelatin-coated polyamide mesh had an anti-inflammatory effect and promoted neovascularization in a rat model.
In July 2022, Onkos Surgical announced that its My3D® Personalized Pelvic Reconstruction system had received 510(k) clearance.
What Does the Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the pelvic reconstruction market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032. The global pelvic reconstruction market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
The research study is based on the product – (vaginal mesh(biological mesh, synthetic mesh), vaginal sling systems, and vaginal pessary), by procedure (non-surgical and surgical (obliterative surgery and reconstructive surgery (native tissue repair, colporrhaphy, sacrocolpopexy, sacrohysteropexy, transvaginal graft, and sling surgery), by indication (pelvic organ prolapse (vaginal prolapse and rectal prolapse), urinary incontinence, interstitial cystitis, and fistulae), by pelvic organs (uterus, ovaries, vagina, and fallopian tubes), by end user (hospitals, ambulatory surgical centers, and specialty clinics), across seven key regions of the world.
Visit for Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-15500
Key Players:
- Coloplast A/S
- Dipromed Srl
- Boston Scientific Corporation (American Medical Systems Inc.)
- pfm medical ag
- Betatech Medical
- Promedon Group
- Caldera Medical
Key Market Segments Covered In Pelvic Reconstruction Industry Research
By Product:
- Vaginal Mesh
- Biological Mesh
- Synthetic Mesh
- Vaginal Sling Systems
- Vaginal Pessary
By Procedure:
- Non-Surgical
- Surgical
- Obliterative surgery
- Reconstructive surgery
- Native Tissue Repair (uterosacral ligament suspension and sacrospinous fixation)
- Colporrhalphy
- Sacrocolpopexy
- Sacrohysteropexy
- Transvaginal graft
- Sling Surgery
By Indication:
- Pelvic Organ Prolapse
- Vaginal Prolapse
- Rectal Prolapse
- Urinary Incontinence
- Interstitial Cystitis
- Fistulae
By Pelvic Organs:
- Uterus
- Ovaries
- Vagina
- Fallopian Tubes
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
